Abstract
A hallmark of serpin function is the massive β-sheet rearrangement involving the insertion of the cleaved reactive loop into β-sheet A as strand s4A. This structural transition is required for inhibitory activity. Small hydrophobic residues at P14 and P12 positions of the reactive loop facilitate this transition, since these residues must pack in the hydrophobic core of the cleaved serpin. Despite the radical substitution of arginine at the P12 position, the crystal structure of cleaved A347R antichymotrypsin reveals full strand s4A insertion with normal β-sheet A geometry; the R347 side chain is buried in the hydrophobic protein core. In contrast, the structure of cleaved P14 T345R antichymotrypsin reveals substantial yet incomplete strand s4A insertion, without burial of the R345 side chain.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gettins, P., Patston, P.A. & Schapira, M. Structure and mechanism of action of serpins. Hemat./Oncol. Clin of North America 6, 1393–1408 (1992).
Potempa, J., Korzuss, E. & Travis, J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269, 15957–15960 (1994).
Schulze, A.J., Huber, R., Bode, W. & Engh, R.A. Structural aspects of serpin inhibition. FEBS Lett. 344, 117–124 (1994).
Travis, J. & Salvesen, G.S. Human plasma proteinase inhibitors. Ann. Rev. Biochem. 52, 655–709 (1983).
Remold-O'Donnell, E. The ovalbumin family of serpin proteins. FEBS Lett. 315, 105–108 (1993).
Doolittle, R.F. Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family. Science 222, 417–419 (1983).
Pemberton, P.A, Stein, P.E., Pepys, M.B., Potter, J.M. & Carrell, R.W. Hormone binding globulins undergo serpin conformational change in inflammation. Nature 336, 257–258 (1988).
Hirayoshi, K. et al. HSP47: a tissue-specific, transformation-sensitive, collagen-binding heat shock protein of chicken embryo fibroblasts. Mol. Cell. Biol. 11, 4036–4044 (1991).
Löbermann, H., Tokuoka, R., Deisenhofer, J. & Huber, R. Human α1-Proteinase inhibitor: crystal structure analysis of two crystal modifications, molecular model, and preliminary analysis of the implications for function. J. Mol. Biol. 177, 531–556 (1984).
Schecter, I. & Berger, A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Comm. 27, 157–162 (1967).
Baumann, U., Huber, R., Bode, W., Grosse, D., Lesjak, M. & Laurell, C.B. Crystal structure of cleaved human α1-antichymotrypsin at 2.7 Å resolution and its comparison with other serpins. J. Mol. Biol. 218, 595–606 (1991).
Baumann, U., Bode, W., Huber, R., Travis, J. & Potempa, J. Crystal structure of cleaved equine leucocyte elastase inhibitor determined at 1.95 Å resolution. J. Mol. Biol. 226, 1207–1218 (1992).
Mourey, L., Samama, J.-P., Delarue, M., Petitou, M., Choay, J. & Moras, D. Crystal structure of cleaved bovine antithrombin III at 3.2 Å resolution. J. Mol. Biol. 232, 223–241. (1993).
Bruch, M., Weiss, V. & Engel, J. Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and a large increase in conformational stability upon cleavage at their reactive sites. J. Biol. Chem. 263, 16626–16630 (1988).
Gettins, P. & Harten, B. Properties of throbin- and elastase-modified human antithrombin III. Biochemistry 27, 3634–3639 (1988).
Carrell, R.W. & Owen, M.C. Plakalbumin, α1-antitrypsin, antithrombin, and the mechanism of inflammatory thrombosis. Nature 317, 730–732 (1985).
Perkins, S.J. et al. Secondary structure changes stabilize the reactive-centre cleaved form of SERPINs. A study by 1H nuclear magnetic resonance and Fourier transform infrared spectroscopy. J. Mol. Biol. 228, 1235–1254 (1992).
Wei, A., Rubin, H., Cooperman, B.S. & Christianson, D.W. Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop. Nature Struct. Biol. 1, 251–258 (1994).
Carrell, R.W., Evans, D.L. & Stein, P.E. Mobile reactive centre of serpins and the control of thrombosis. Nature 353, 576–578 (1991).
Schulze, A.J. et al. Structural transition of α1-antitrypsin by a peptide sequentially similar to β-Strand s4A. Eur. J. Biochem. 194, 51–56 (1990).
Hood, D.B., Huntington, J.A. & Gettins, P.G.W. & Gettins, P.G.W. α1-Proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways. Biochemistry 33, 8538–8547 (1994).
Hopkins, P.C.R. & Stone, S.R. The contribution of conserved hinge region residues of α1-antitrypsin to its reaction with elastase. Biochemistry 34, 15872–15879 (1995).
Lawrence, D.A., Olson, S.T., Palaniappan, S. & Ginsburg, D. Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition. J. Biol. Chem. 269, 27657–27662 (1994).
Tucker, H.M., Mottonen, J., Goldsmith, E.J. & Gerard, R.D. Engineering of plasminogen activator inhibitor-1 to reduce the rate of latency transition. Nature Struct. Biol. 2, 442–445 (1995).
Katz, D.S., Wei, A., Zhong, Q., Rubin, H., Cooperman, B.S. & Christianson, D.W. Crystallization and atomic resolution X-ray diffraction analysis of antichymotrypsin variants. Biochem. Biophys. Res. Comm. 196, 752–757 (1993).
Gils, A., Knockaert, I. & Declerck, P.J. Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop. Biochemistry 35, 7474–7481 (1996).
Aertgeerts, K., De Bondt, H.L., De Ranter, C.J. & Declerck, P.J. Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1. Nature Struct. Biol. 2, 891–897 (1995).
Audenaert, A.-M., Knockaert, I., Collen, D. & Declerck, P.J. Conversion of plasminogen activator inhibitor-1 from inhibitor to substrate by point mutations in the reactive site loop. J. Biol. Chem. 269, 19559–19564 (1994).
Carrell, R.W. & Stein, P.E. The biostructural pathology of the serpins: critical function of sheet opening mechanism. Biol. Chem. Hoppe-Seyler 377, 1–17 (1996).
Sancho, E., Declerck, P.J., Price, N.C., Kelly, S.M. & Booth, N.A. Conformational studies on plasminogen activator inhibitor (PAI-1) in active, latent, substrate, and cleaved forms. Biochemistry 34, 1064–1069 (1995).
Wright, H.T. & Blajchman, M.A. Proteolytically cleaved mutant antithrombin-Hamilton has high stability to denaturation characteristic of wild type inhibitor serpin. FEBS Lett. 348, 14–16 (1994).
Gettins, P., Patston, P. & Schapira, M. The role of conformational change in serpin structure and function. BioEssays 15, 461–467 (1993).
Wright, H.T. & Scarsdale, J.N. Structural basis for serpin inhibitor activity. Proteins: Struct., Funct., Gen. 22, 210–225 (1995).
Stites, W.E., Gittis, A.G., Lattman, E.E. & Shortle, D. In a staphylococcal nuclease mutant the side-chain of a lysine replacing valine 66 is fully buried in the hydrophobic core. J. Mol. Biol. 221, 7–14 (1991).
Dao-pin, S., Anderson, D.E., Baase, W.A., Dahlquist, F.W. & Matthews, B.W. Structural and thermodynamic consequences of burying a charged residue within the hydrophobic core of T4 lysozyme. Biochemistry 30, 115221–111529 (1991).
Wright, H.T., Qian, H.X. & Huber, R. Crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin. Its relationship to the structure of cleaved α1-proteinase inhibitor. J. Mol. Biol. 213, 513–528 (1990).
Stein, P.E., Tewkesbury, D.A. & Carrell, R.W. Ovalbumin and angiotensinogen lack serpin S→R conformational change. Biochem. J. 262, 103–107 (1989).
Schulze, A.J., Huber, R., Degryse, E., Speck, D. & Bischoff, R. Inhibitory activity and conformational transition of α1-proteinase inhibitor variants. Eur. J. Biochem. 202, 1147–1155 (1991).
Skriver, K. et al. Substrate properties of C1 inhibitor Ma (Alanine 434→GIutamic Acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor inhibitor/substrate status. J. Biol. Chem. 266, 9216–9221 (1991).
Davis, A.E. et al. C1 inhibitor hinge region mutations produce dysfunction by different mechanisms. Nature Genetics 1, 354–358 (1992).
Lawrence, D.A. et al. Serpin-protease complexes are trapped as stable acyl-enzyme intermediates. J. Biol. Chem. 270, 25309–25312 (1995).
Lee, N.K., Park, S.D. & Yu, M.-H. Probing the native strain in α1-antitrypsin. Nature Struct. Biol. 3, 497–500 (1996).
Ireland, H. et al. Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin. Brit. J. Haem. 79, 70–74 (1991).
Hopkins, P.C.R., Carrell, R.W. & Stone, S.R. Effects of mutations in the hinge region of serpins. Biochemistry 32, 7650–7657 (1993).
Song, H.K., Lee, K.N., Kwon, K.-S., Yu, M.-H. & Suh, S.W. Crystal structure of an uncleaved α1-antitrypsin reveals the conformation of its inhibitory reactive loop. FEBS Letters 377, 150–154 (1995).
Wilczynska, M., Fa, M., Ohlsson, P.-I. & Ny, T. The inhibition mechanism of serpins. J. Biol. Chem. 270, 29652–29655 (1995).
Carrell, R.W., Stein, P.E., Fermi, G. & Wardell, M.R. Biological implications of a 3 Å structure of dimeric antithrombin. Structure 2, 257–270 (1994).
Schreuder, H.A. et al. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Nature Struct. Biol. 1, 48–54 (1994).
Stein, P.E. & Carrell, R.W. What do dysfunctional serpins tell us about molecular mobility and disease? Nature Struct. Biol. 2, 96–113 (1995).
Plotnick, M.I., Mayne, L., Schechter, N.M. & Rubin, H. Distortion of the active site of chymotrypsin complexed with a serpin. Biochemistry 35, 7586–7590 (1996).
Stavridi, E.S. et al. Structural change in α-chymotrypsin induced by complexation with α1-antichymotrypsin as seen by enhanced sensitivity to proteolysis. Biochemistry 35, 10608–10615 (1996).
Dixon, M.M. & Matthews, B.W. Is γ-chymotrypsin a tetrapeptide acyl-enzyme adduct of α-chymotrypsin? Biochemistry 28, 7033–7038 (1989).
Rubin, H. et al. Cloning, expression, purification, and biological activity of recombinant native and variant α1-antichymotrypsin. J. Biol. Chem. 265, 1199–1207 (1990).
Kabsch, W. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Cryst. 24, 795–800 (1993).
Leslie, A.G.W. Joint CCP4 and ESF-EACMB Newsletter on Protein Crystallography, 26, Warrington, Daresbury Laboratory (1992).
Collaborative Computing Project, No.4. The CCP4 Suite: Programs for protein crystallography. Acta Cryst. D50, 760–763 (1994).
Navaza, J. AMoRe: An automated package for molecular replacement. Acta Cryst. A50, 157–163 (1994).
Brünger, A.T. Free R value: A novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472–475 (1992).
Sack, J.S. CHAIN: A crystallographic modeling program. J. Mol Graphics 6, 224–225 (1988).
Brünger, A.T. X-PLOR (v.3.1)- A system for X-ray crystallography and NMR, New Haven, CT., Yale University Press (1992).
Brünger, A.T., Krukowski, A. & Erickson, J.W. Slow-cooling protocols for crystallographic refinement by simulated annealing. Acta. Cryst. A46, 585–593 (1990).
Rubin, H. et al. Conversion of α1-Antichymotrypsin into a human neutrophil elastase inhibitor: demonstration of variants with different association rate constants, stoichiometries of inhibition, and complex stabilities. Biochemistry 33, 7627–7633 (1994).
Jones, T.A., Cowan, S.W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Cryst. A47, 110–119 (1991).
Jones, T.A. & Kjeldgaard, M. O - the Manual (version 5.10), Uppsala (1995).
Kraulis, P.J. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24, 946–950 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lukacs, C., Zhong, J., Plotnick, M. et al. Arginine substitutions in the hinge region of antichymotrypsin affect serpin β-sheet rearrangement. Nat Struct Mol Biol 3, 888–893 (1996). https://doi.org/10.1038/nsb1096-888
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nsb1096-888